Niva Bupa Health Insurance Company
The model puts Niva Bupa Health Insurance Company at ₹77 per share — 0.0% above today's price.
Model estimate · 5 yrs of reported financials · dated 16 Nov 2026
All values are mathematically derived from financial models and do not constitute buy, sell, or hold recommendations. Models rely on historical data and assumptions that may not reflect future outcomes. StockRank is not a registered investment advisor — always do your own research before making investment decisions.
DCF model history
NIVABUPA is close to its usual level against the model.It was this cheap or cheaper on 75% of days in the past 5 years.
NIVABUPA is in its usual valuation range
Cheaper than on 25% of days over 5 years
After days like today
Past results do not predict future returns.
360° view
The takeaway
A fast-growing Indian health insurer with strong reported revenue and profit momentum, but thin underwriting margins and low accounting returns leave its earnings quality the main trade-off.
↗ Strengths
- Reported revenue and earnings growth have been strong over recent years, with latest quarterly revenue and profit also up sharply year on year.
- The insurer has recorded positive standalone common equity and profitable reported earnings in each of the last three years.
- Promoter holding is 55.3% with no reported promoter pledging as of the latest shareholding date.
↘ Risks to watch
- The standardized combined ratio is above 100, indicating reported underwriting costs exceeded premiums before investment income.
- Latest annual return on equity was low at about 4%, and the worst of the last three annual returns was weaker still.
- The health assessment is a limited accounting and underwriting view, not evidence on regulatory solvency, reserves or claims adequacy; long-run growth data are incomplete.
Niva Bupa Health Insurance Company Limited provides health insurance in India, including individual, family, senior-citizen, personal accident, critical illness, hospital cash and maternity plans, plus international and study-abroad travel cover and corporate group health products. It was incorporated in 2008, was formerly Max Bupa Health Insurance, and is based in Gurugram. Reported business segments are Health, Personal Accident and Travel, with operations reported in India.
Key metrics
Latest reported · price-based figures use the EOD quote5 scoring axes
How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.
75/100How cheaply the stock is priced relative to earnings, assets, and cash flows vs peers.
- Market value of equity relative to reported shareholder equity. Asset quality, profitability and accounting practices affect how the ratio should be read.
- 4.55×
- Share price relative to earnings per share over the trailing 12 months. Growth, risk and one-off earnings can affect this ratio; it is not meaningful when earnings are nonpositive.
- 27.46×
- P/E divided by the earnings-growth rate used in the ratio. Its meaning depends on that growth period and whether growth is sustainable.
- 0.06×
- Percentage difference between the saved valuation estimate and its reference share price. It depends on assumptions and is not a forecast return.
- -1.67%
Profitability, capital efficiency, and consistency of cash generation.
42/100Profitability, capital efficiency, and consistency of cash generation.
- Net profit relative to total assets. It indicates how assets generate earnings; comparisons depend on the type of business and asset quality.
- 1.15%
- Net profit relative to shareholder equity. Debt or a small equity base can raise this ratio without improving the underlying business.
- 4.08%
- The share of observed annual periods with positive common earnings within the last ten years. It describes profit frequency, not the size or stability of those profits.
- 66.67%
Revenue and earnings growth rates across multiple time horizons.
100/100Revenue and earnings growth rates across multiple time horizons.
- Earnings-per-share growth expressed as a compounded annual rate over three years. Changes in share count and one-off profits can affect the rate.
- 116.46%
- Net profit growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
- 118.48%
- Net profit growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
- —
- Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
- 63.39%
- Revenue growth expressed as a compounded annual rate over 3 years. It smooths year-to-year changes and does not predict future growth.
- 32.88%
- Revenue growth expressed as a compounded annual rate over 5 years. It smooths year-to-year changes and does not predict future growth.
- 41.44%
Balance sheet strength, leverage, and financial stability.
61/100Balance sheet strength, leverage, and financial stability.
- A general insurer’s claims and operating expenses relative to earned premiums. A ratio above 100% indicates an underwriting loss before investment income; it does not establish solvency or reserve adequacy.
- 101.44%
- The share of promoter holdings pledged as collateral. Pledging can create financing pressure if collateral values fall; zero pledging does not remove other risks.
- 0.00%
- The percentage of three consecutive annual periods with positive common earnings. It describes profit frequency, not insurer solvency or the adequacy of reserves.
- 100.00%
- The percentage of shares held by promoters. Ownership concentration can align interests but does not by itself establish governance quality.
- 55.30%
- The lowest annual common profit relative to opening common equity across three consecutive years. It describes past earnings resilience, not insurer solvency or claims-paying capacity.
- 4.28%
Recent price moves and changes in earnings and institutional ownership.
74/100Recent price moves and changes in earnings and institutional ownership.
- Change in the share of equity held by domestic institutional investors over one year, in percentage points. It describes ownership changes, not the cash they invested or future returns.
- 0.60 pp
- Net profit change from the same quarter a year earlier. One-off items and a small comparison-period profit can make the percentage unusually large.
- 484.58%
- Revenue change from the same quarter a year earlier. It reduces seasonal differences, but a weak comparison period can amplify growth.
- 63.39%
- Share-price change over one year. Past price performance does not predict future returns.
- 2.87%
- Share-price change over three years in total, not per year. Past price performance does not predict future returns.
- —
Peer Companies
General InsuranceQuarterly Results
₹ Cr · per share in ₹| Particulars | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 | Jun '26 | Sep '26 |
|---|---|---|---|---|---|---|---|---|
| − Revenue | ||||||||
| Revenue | 1,258.02 | 1,670.79 | 1,371.08 | 1,574.03 | 1,611.03 | 2,138.56 | 2,471.26 | 2,571.88 |
| Revenue Growth YoY | 22.65% | 27.00% | 21.96% | 19.13% | 28.06% | 28.00% | 80.24% | 63.39% |
| − Profitability | ||||||||
| Operating Profit | -23.66 | 250.66 | -93.01 | -53.21 | -94.21 | 365.23 | 298.43 | 285.60 |
| OPM % | -1.88% | 15.00% | -6.78% | -3.38% | -5.85% | 17.08% | 12.08% | 11.10% |
| Profit Before Tax | 13.24 | 206.08 | -91.44 | -35.27 | -87.64 | 341.16 | 183.74 | 181.53 |
| − Bottom Line | ||||||||
| Net Profit | 13.24 | 206.08 | -91.44 | -35.27 | -87.64 | 345.13 | 137.80 | 135.64 |
| Net Profit Growth YoY | 189.08% | 31.21% | -385.84% | -370.89% | -761.93% | 67.47% | 250.70% | 484.58% |
| EPS | 0.07 | 1.13 | -0.50 | -0.19 | -0.47 | 1.87 | 0.75 | 0.73 |
Income Statement
Annual · ₹ Cr · per share in ₹| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| − Revenue | ||||||
| Revenue | 1,182.61 | 1,877.35 | 2,853.07 | 4,115.47 | 5,374.28 | 6,694.69 |
| Revenue Growth | — | 58.75% | 51.97% | 44.25% | 30.59% | 24.57% |
| − Expenses & Profitability | ||||||
| Operating Profit | -252.21 | -441.45 | -311.33 | -83.08 | 146.37 | 216.17 |
| OPM % | -17.85% | -20.45% | -9.65% | -1.92% | 2.65% | 3.23% |
| Profit Before Tax | -49.74 | -196.52 | 12.54 | 81.85 | 213.52 | 126.81 |
| − Bottom Line | ||||||
| Net Profit | -49.74 | -196.52 | 12.54 | 81.85 | 213.52 | 130.78 |
| Profit Growth | — | — | — | 552.71% | 160.87% | -38.75% |
| EPS | -0.43 | -1.42 | 0.09 | 0.51 | 1.22 | 0.71 |
| Dividend / Share | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · ₹ CrLiabilities shown exclude shareholders’ funds and other equity. Assets equal liabilities plus equity.
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| − Equity | ||||||
| Shareholders' Funds | 576.81 | 505.64 | 827.76 | 2,050.42 | 3,054.57 | 3,198.64 |
| − Liabilities | ||||||
| Total Borrowings | 0.00 | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| Total Current Liabilities | 1,322.23 | 1,982.78 | 2,798.49 | 3,891.22 | 6,452.39 | 7,823.94 |
| Total Liabilities | 1,322.24 | 2,232.79 | 3,048.81 | 4,141.26 | 6,703.07 | 8,077.22 |
| − Assets | ||||||
| Fixed Assets | 47.52 | 49.68 | 55.58 | 58.81 | 75.25 | 87.99 |
| Investments | 1,621.56 | 2,401.32 | 3,366.10 | 5,458.23 | 8,175.08 | 9,669.65 |
| Cash & Equivalents | 30.41 | 58.81 | 101.86 | 142.82 | 220.35 | 158.66 |
| Total Current Assets | 229.96 | 287.44 | 454.89 | 674.83 | 1,509.83 | 1,483.79 |
| Total Assets | 1,899.04 | 2,738.44 | 3,876.56 | 6,191.87 | 9,760.16 | 11,275.86 |
Cash Flow
Annual · ₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| − Cash Flows | ||||||
| Cash from Operations | 0.00 | 337.82 | 592.51 | 812.52 | 1,654.16 | 904.86 |
| Cash from Investing | 0.00 | -723.17 | -829.39 | -1,881.59 | -2,347.60 | -961.34 |
| Cash from Financing | 0.00 | 373.76 | 279.93 | 1,110.02 | 770.97 | -5.21 |
| Net Cash Flow | 0.00 | -11.59 | 43.05 | 40.96 | 77.53 | -61.69 |
| − Cash Position | ||||||
| Closing Cash | 0.00 | 58.81 | 101.86 | 142.82 | 220.35 | 158.66 |
Shareholding Pattern
Promoters hold 55.3% of Niva Bupa Health Insurance Company, more than half. Since 13 Nov 2024, public shareholders’ share has fallen from 25.8% to 15.9%, while Indian institutions’ share has risen from 9.6% to 15.9%.
| Holder | 13 Nov ’24 | Dec ’24 | Mar ’25 | Jun ’25 | Sep ’25 | Dec ’25 | Mar ’26 | Jun ’26 | Sep ’26 |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 56.0% | 56.0% | 56.0% | 55.4% | 55.4% | 55.4% | 55.4% | 55.3% | 55.3% |
| Foreign institutions FII | 8.6% | 8.9% | 8.9% | 10.8% | 10.7% | 10.3% | 10.6% | 12.1% | 13.0% |
| Indian institutions DII | 9.6% | 9.8% | 9.7% | 15.1% | 15.3% | 16.0% | 16.5% | 16.2% | 15.9% |
| Public | 25.8% | 25.4% | 25.4% | 18.7% | 18.6% | 18.3% | 17.6% | 16.4% | 15.9% |
Darker shading marks the quarters when that holder owned more.
Dividend History
No dividends are on record for Niva Bupa Health Insurance Company.




